RankAlpha logo
Back to Rankings

APRE

Aprea TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
APRE vs peer average
34/100
APRE vs. peer average (F vs. D)
Grade spread
B 1 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

BOLT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $9.07M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBOLTBolt Biotherapeutics
APRE
Aprea Therapeutics
BOLT
Bolt Biotherapeutics
Grade
F
C
Momentum
10
41
Value
58
58
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs BOLT

APRE / BOLT
Grade Position
Below peers
APRE vs. peer average (F vs. D)
34/100
Momentum
10
BOLT
Value
58
APRE
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs APRE
1
BOLT
Bolt Biotherapeutics Inc Common
C
60/100
-2
2
BRTX
BioRestorative Therapies Inc Common
F
20/100
Even
3
QNRX
Quoin Pharmaceuticals. Ltd ADR
D
40/100
-1
4
CURX
Curanex Pharmaceuticals Inc Common
N/A
-
-
5
APM
Aptorum Group Ltd Class A Common
F
20/100
Even
BOLT is the first peer returned for this comparison set.